medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2003, Number 4

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2003; 16 (4)

Consequences of a Murderer (NK).

Rosas MLP, Abarca RE, Nava RH, Zamudio CP

Language: Spanish
References: 27
Page: 257-260
PDF size: 100.45 Kb.


ABSTRACT

The NK cells are part of the innate immune system. Morphologically they are big lymphocytes and have many intracytoplasmic granules. When they are activated they become cells of short period of life whose function is to identify and trap any cells showing molecular patrons that imply risk either by stress, by malign transformation or by viral infection and other intracellular pathogen agents. They also control the hematopoietic cells growth producing a great variety of cytokines and chemokines. Recent investigations allow us to suggest the study of NK cells in their roll of bioenergetic model for a cellular differentiation study.


REFERENCES

  1. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar Mather TP. Natural Killer Cells in Antiviral Defense: Function and Regulation by Innate Cytokines. Ann Rev Immunol 1999;17:189-220.

  2. Murphy WJ, Koh CY, Raziuddi A, Bennett M, Longo DL. Immunobiology of Natural Killer Cells and Bone Marrow Transplantation: Merging of Basic and Preclinical Studies. Immunol Rev 2001;181:279-289.

  3. Diefenbach A, Raulet D. Strategies for Target Cell Recognition by Natural Killer Cells. Immuno Rev 2001;181:170-184.

  4. Moffet-King A. Natural Killer Cells and Pregnancy. Nat Rev Immunol 2002;2:656-663.

  5. Yuan D, Koh CY, Wilder JA. Interactions between B Lymphocytes and NK Cells. FASEB J 1994;8:1012-1018.

  6. Moretta L, Biassoni R, Bottino C, Mingari C, Moretta A. Natural Killer Cells: a Mystery no More. Scand J Immunol 2002;55:229-232.

  7. Cooper MA, Fehniger TA, Caligiuri MA. The Biology of Human Natural Killer-Cell Subsets. Trends Immunol 2001; 22:633-640.

  8. Djeu DY, Jiang K, Wei S. A Vie to a Kill: Signals Triggering Cytotoxicity. Clin Cancer Res 2002;8:636-640.

  9. Jiang K, Zhong B, Gilvary DL, Corliss BC, Vivier E, Hong-Geller E, et al. Sky Regulation of Phosphoinositide 3-kinase-dependent NK Cell Function. J Immunol 2002;168:3155-3164.

  10. Gronh V, Rhinehart R, Secrits H, Bauer S, Grabstein K, Spies T. Broad Tumor-associated Expression and Recognition by Tumor-derived gd T Cells of MICA and MICB. PNAS 1999;96:6879-6884.

  11. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, et al. ULPBs, Novel MHC Class-I-related Molecules, bind to CMV Glycoprotein UL-16 and Stimulate NK Cytotoxicity Througth the NKG2D Receptor. Immunity 2001;14:123-133.

  12. Biassoni R, Cantón C, Pende D, Sivori S, Parolini S, Vitale M, et al. Human Natural Killer Cell Receptors and Coreceptors. Immunol Rev 2001;181:203-214.

  13. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating Receptors and Coreceptors involved in Human Natural Killer Cell-mediated Cytolysis. Ann Rev Immunol 2001;19:197-223.

  14. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, et al. NK p44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, is Involved non-major Histocompatibility Complex-restricted Tumor Cells Lysis. J Exp Med 1998;187:2065-2072.

  15. Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L, et al. Identification and Molecular Characterization of NKp30, a novel-triggering Receptor involved in Natural Cytotoxicity mediated by Human Natural Killer Cells. J Exp Med 1999;190:1505-1516.

  16. Mandelboim O, Lieberman N, Lev MP, Arnon TI, Bushkin Y, Davis D, et al. Recognition of Haemagglutinins on Virus-infected Cells by NKp46 Activates Lysis by human NK Cells. Nature 2001;409: 1055-1060.

  17. Colucci F, Di Santo J, Leibson P. Natural Killer Cell Activation in Mice and Men: Different Triggers for Similar Weapons? Nat Immunol 2002;3:807-813.

  18. Leibson PJ. Signal Transduction during Natural Killer Cell Activation: inside the Mind of a Killer. Immunity 1997;6:655-661.

  19. Perussia B. Signaling for Cytotoxicity. Nat Immunol 2000;1:372-374.

  20. Jiang K, Zhong B, Gilvary DL, Corliss BC, Hong-Geller E, Wei S, et al. Pivotal Role of Phosphoinositide-3 kinase in Regulation of Cytotoxicity in Natural Killers Cells. Nature Immunol 2000;1:419-425.

  21. Jiang K, Zhong B, Ritchey C, Gilvary DL, Hong-Geller E, Wei S, et al. Regulation of Akt Dependent Cell Survival by Sky and Rac. Blood 2003;101:236-244.

  22. Frauwirth KA, Riley JL, Harris MH, Prry RV, Rathmell JC, Plas DR, et al. The CD28 Signaling Pathway regulates Glucose Metabolism. Immunity 2002;16:769-777.

  23. Raulet DH, Vance RE, McMahon C. Regulation of the Natural Killer Cell Receptor Repertoire. Ann Rev Immunol 2001;19:291-330.

  24. Janeway C, Medzhitov R. Innate Immune Recognition. Ann Rev Immunol 2002;20:197-216.

  25. Vander HMG, Chandel NS, Schumacker PT, Thompson CB. Bcl-xL prevents Cell Death Following Growth Factor Withdrawal by Facilitating Mitochondrial ATP/ADP Exchange. Mol Cell 1999;3:159-167.

  26. Chen W, Jin W, Tian H, Sicurello P, Frank M, Orenstein JM, et al. Requirement for Transforming Growth Factor b1 in Controlling T Cell Apoptosis. J Exp Med 2001;194:439-453.

  27. Green D, Droin N, Pinkoski M. Activation-induced Cell Death in T Cells. Immunol Rev 2003;193:70-80.




2020     |     www.medigraphic.com